Oxbryta Alternatives Compared
| Oxbryta (voxelotor) | Casgevy (exagamglogene autotemcel) | Voxelotor |
|
|---|
| Oxbryta (voxelotor) | Casgevy (exagamglogene autotemcel) | Voxelotor |
|
|---|---|---|---|
|
Prescription only
Prescribed for Sickle Cell Disease. Oxbryta may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Beta Thalassemia, Sickle Cell Disease. Casgevy may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Sickle Cell Disease. Voxelotor may also be used for purposes not listed in this medication guide. |
Related suggestions Sickle Cell Disease
|
| More about Oxbryta (voxelotor) | More about Casgevy (exagamglogene autotemcel) | More about Voxelotor | |
| Ratings & Reviews | |||
|
Oxbryta has an average rating of 5.9 out of 10 from a total of 7 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 43% reported a negative effect. |
Be the first to share your experience with this drug. |
Voxelotor has an average rating of 6.1 out of 10 from a total of 8 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 38% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
|
View all Oxbryta side effects |
View all Casgevy side effects |
View all Voxelotor side effects |
|
| Drug Class | |||
| Generic Availability | |||
|
N/A |
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | |||
|
|
N/A |
|
| Brand Names | |||
|
N/A |
N/A |
N/A |
|
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
|
35.5 hours |
N/A |
35.5 hours |
|
| CSA Schedule 1 View glossary of CSA terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | |||
|
A total of 373 drugs are known to interact with Oxbryta:
|
A total of 96 drugs are known to interact with Casgevy:
|
A total of 373 drugs are known to interact with Voxelotor:
|
|
| Alcohol/Food/Lifestyle Interactions | |||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
| Disease Interactions | |||
| First Approval Date | |||
|
November 25, 2019 |
N/A |
November 25, 2019 |
|
| WADA Class View classifications | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient Resources | |||
| Professional Resources | |||
|
N/A |
|||
| Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.